BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Sangamo BioSciences

Sangamo BioSciences logo

Geography
United States of America based
Funding
$74.200 M

Sangamo is a clinical stage biopharmaceutical company focused on the research, development and commercialization of engineered zinc finger DNA-binding proteins (ZFPs) as novel ZFP Therapeutics targeting various monogenic and infectious diseases with unmet medical needs.

Technologies

Gene Therapy Startups   Pharmaceutical and Drug Discovery  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet